Clinical Trial

Intraoperative Assessment of Microcirculatory Function Using Vascular Occlusion Test During Liver Transplantation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Early allograft dysfunction (EAD) remains one of the most important complications following orthotopic liver transplantation (OLT). Currently, there is no established intraoperative biomarker that reliably predicts graft dysfunction at an early stage. Near-infrared spectroscopy (NIRS) combined with the vascular occlusion test (VOT) is a non-invasive method for assessing tissue oxygenation and microcirculatory reserve. This prospective observational study aims to investigate whether VOT-derived parameters, including desaturation slope, recovery slope and post-ischemic hyperemic area under the curve (AUC-H), can predict EAD in liver transplant recipients. Measurements will be performed at four predefined intraoperative timepoints: after induction of anesthesia, during the anhepatic phase, during the neohepatic phase and at the end of surgery. The primary outcome is the occurrence of EAD according to Olthoff criteria.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-15.
Trial Details
NCT Number NCT07658794
Lead Sponsor Ippokrateio General Hospital of Thessaloniki
Conditions Liver Cirrhosis, Early Allograft Dysfunction
Enrollment 50 participants
Start Date 2026-06
Primary Completion 2027-03 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-01